The Patent Finder
US

Compositions comprising pharmaceutically acceptable salts of amylin analogs and uses thereof

US 12,337,029 In force
OverviewFamilyAssignmentsSources & methods

Term ends Nov 10, 2042 · Low confidence

Filed Feb 16, 2024 as application 18/444,485 · Granted Jun 24, 2025
Base term, 20 years from filing
Today
20 years from filing
2022 2042
Clock starts
Nov 10, 2022
Term ends
Nov 10, 2042
Granted
Jun 24, 2025
base term Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 12,233,112, to Nov 10, 2042. The term already ends on or before that date, so the cap shortened nothing.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
8
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 0 of 3 maintenance fees are paid so far. Confidence: Low. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Nov 10, 2022, when application PCT/US2022/049585, the earliest non-provisional in its chain, was filed (this one was filed Feb 16, 2024); a parent in its chain could not be resolved (the next row)Nov 10, 2042High confidence
Continuity chainA parent in the chain could not be resolveddated from this application's own claimMedium confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 12,233,112)resolves to Nov 10, 2042, no earlier than this term, so no changeHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events0 of 3 maintenance fees paidIn forceHigh confidence
Further caveats on recordThe record names parents not resolved: PCTUS2022049585Low confidence overallLow confidence
Computed term endThe steps above, in orderNov 10, 2042Low confidence

This family

Application PCT/US2022/049585PCT application
no patent term
no patent term
US 12,233,110In force
Nov 2042
Nov 2042
US 12,233,111In force
Nov 2042
Nov 2042
US 12,233,112In force
Nov 2042
Nov 2042
US 12,337,029this patent
Nov 2042
Nov 2042
US 12,350,320In force
Nov 2042
Nov 2042
Application 18/946,213Pending
not computed
not computed
Application 18/960,864Pending
not computed
not computed
Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Mar 18, 2024
Reel 66811, frame 242
Brown, Tyler; Ibsen, KellyI2O Therapeutics, Inc.Assignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited